Insights

Sustainable sourcing Target Evolutia Bio as a partner for scalable bio-based ingredient production, emphasizing sustainability and higher purity by precision fermentation. Pitch collaborations to supply consumer care, food & beverage, and pharmaceutical brands seeking greener alternatives to traditional extraction or chemical synthesis.

Bio-based expansion Leverage the company’s focus on plant-, animal-, and petrochemical-derived ingredients to propose cross-vertical applications, including contract research, process development, and tolling arrangements for specialty ingredients, enabling faster routes to market for new product lines.

Tech-enabled efficiency Highlight Evolutia Bio’s use of cloud and automation tooling (AWS, Terraform, Docker, Opentrons) to position as a modern partner capable of scalable, reproducible fermentation workflows and rapid iteration, appealing to clients needing reliable supply and confidential IP management.

Strategic partnerships Explore co-development and licensing discussions with potential pharma, nutrition, and consumer goods manufacturers, citing existing industry trend momentum in sustainable manufacturing and the company’s alignment with high-purity ingredient production.

Financial health signals Frame Evolutia Bio as an growing early-stage player with solid revenue potential and sizable funding, suggesting opportunities for strategic investment, joint ventures, or multi-year supply agreements to secure capacity and enhance go-to-market timelines.

Similar companies to Evolutia Bio

Evolutia Bio Tech Stack

Evolutia Bio uses 8 technology products and services including Amazon Web Services, HashiCorp Terraform, Docker, and more. Explore Evolutia Bio's tech stack below.

Media & News

Evolutia Bio's Email Address Formats

Evolutia Bio uses at least 1 email format:
Evolutia Bio Email FormatsExamplePercentage
F.Last@willowbio.comJ.Doe@willowbio.com
100%

Frequently Asked Questions

What is Evolutia Bio's official website and social media links?

Minus sign iconPlus sign icon
Evolutia Bio's official website is evolutiabio.com and has social profiles on LinkedIn.

How much revenue does Evolutia Bio generate?

Minus sign iconPlus sign icon
As of August 2026, Evolutia Bio's annual revenue is estimated to be $10M - $25M.

What is Evolutia Bio's SIC code and NAICS code?

Minus sign iconPlus sign icon
Evolutia Bio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evolutia Bio have currently?

Minus sign iconPlus sign icon
As of August 2026, Evolutia Bio has approximately 25 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: P. F., Director: P. S. and Member Board Of Directors: R. A. Explore Evolutia Bio's employee directory with LeadIQ.

What industry does Evolutia Bio belong to?

Minus sign iconPlus sign icon
Evolutia Bio operates in the Biotechnology Research industry.

What technology does Evolutia Bio use?

Minus sign iconPlus sign icon
Evolutia Bio's tech stack includes Amazon Web Services, HashiCorp Terraform, Docker, WordPress, PostgreSQL, Microsoft 365, Opentrons and Box.

What is Evolutia Bio's email format?

Minus sign iconPlus sign icon
Evolutia Bio's email format typically follows the pattern of F.Last@willowbio.com. Find more Evolutia Bio email formats with LeadIQ.

How much funding has Evolutia Bio raised to date?

Minus sign iconPlus sign icon
As of August 2026, Evolutia Bio has raised $63M in funding. The last funding round occurred on May 08, 2025.

When was Evolutia Bio founded?

Minus sign iconPlus sign icon
Evolutia Bio was founded in 2019.
Evolutia Bio logo

Evolutia Bio

Biotechnology ResearchCalifornia, United States11-50 Employees

Evolutia Bio is a biotechnology research company based in Sunnyvale, California, focused on developing bio-based production processes for ingredients used across consumer care, food and beverage, and pharmaceutical applications. Its scientists engineer microorganisms to produce ingredients derived from plants, animals, or petrochemicals via precision fermentation. The company aims to offer processes that are more sustainable, secure, and cost-effective than traditional extraction or chemical synthesis routes, typically yielding higher-purity products.

Evolutia Bio operates as a smaller firm within the biotech field and pursues collaborations to advance its product portfolio. The company, formerly known as Willow Biosciences, disclosed a corporate update in 2024 outlining progress and partnerships, including an agreement with Laurus Labs.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $63M

    Evolutia Bio has raised a total of $63M of funding over 8 rounds. Their latest funding round was raised on May 08, 2025 as a Post IPO Equity.

  • $10M - $25M

    Evolutia Bio's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.